Placental Abruption

Quick Reference

Critical Alerts

• Placental abruption is the leading cause of perinatal mortality in third-trimester bleeding, accounting for 40-50% of fetal deaths [1]
• Concealed abruption (10-20% of cases) may present with minimal vaginal bleeding despite massive retroplacental hemorrhage up to 2,000 mL [2]
• DIC develops in 10-20% of severe abruptions and up to 38% when associated with fetal demise [3]
• Fetal mortality ranges from 20-40% with significant abruptions and approaches 100% with > 50% placental separation [4]
• Immediate delivery is indicated for maternal hemodynamic instability, non-reassuring fetal status, or progressive abruption despite resuscitation [5]
• Recurrence risk is 5-17% after one abruption and 20-25% after two previous abruptions [6]

Key Diagnostics

• Clinical diagnosis primarily - do not delay management for imaging confirmation [7]
• Continuous fetal monitoring (cardiotocography/electronic fetal monitoring) mandatory
• Coagulation panel: CBC, PT, PTT, fibrinogen, D-dimer, platelet count
• Type and crossmatch: Anticipate massive transfusion (6+ units pRBCs)
• Kleihauer-Betke test: Quantify fetomaternal hemorrhage in Rh-negative mothers
• Bedside ultrasound: May show retroplacental clot (sensitivity only 25-60%), but normal ultrasound does NOT exclude diagnosis [8]

Emergency Treatments

• Large-bore IV access: Two 16-18G peripheral IVs minimum
• Aggressive fluid resuscitation: Initial 2L crystalloid, transition to blood products early
• Activate massive transfusion protocol if:
  • SBP less than 90 mmHg despite initial 2L crystalloid
  • Ongoing hemorrhage with hemodynamic instability
  • Evidence of coagulopathy (fibrinogen less than 200 mg/dL)
• Correct coagulopathy proactively:
  • "FFP: 1:1 ratio with pRBCs"
  • "Cryoprecipitate: Target fibrinogen > 200 mg/dL (> 300 mg/dL if ongoing bleeding)"
  • "Platelets: Target > 50,000/μL (> 75,000/μL for cesarean section)"
• Tranexamic acid: 1g IV over 10 minutes if hemorrhage within 3 hours of administration [9]
• Immediate obstetric consultation: Decision regarding delivery timing and mode
• Emergency cesarean section if:
  • "Category 1: Maternal hemodynamic instability or non-reassuring fetal status"
  • "Decision-to-delivery interval target: less than 30 minutes"

---

Definition and Overview

Placental abruption (abruptio placentae) is the premature separation of a normally implanted placenta from the uterine wall before delivery of the fetus, occurring after 20 weeks of gestation. It represents a critical obstetric emergency with significant maternal and perinatal morbidity and mortality.

The condition results from bleeding into the decidua basalis, which leads to separation of the placenta from the uterine wall. The extent of separation determines clinical severity, ranging from small marginal abruptions discovered incidentally after delivery to catastrophic complete abruption with maternal hemorrhagic shock and fetal demise.

Global Epidemiology

Incidence and Prevalence

• Overall incidence: 0.4-1.0% of all pregnancies worldwide [1]
• Regional variation:
  • "Developed countries: 0.5-0.8%"
  • "Developing countries: Up to 1.5% (higher due to untreated hypertension, poor nutrition)"
• Severe abruption requiring emergency delivery: 0.2-0.4% of pregnancies [10]

Temporal Trends

• Incidence has remained relatively stable over past 30 years
• Improved outcomes due to:
  • Earlier recognition and intervention
  • Enhanced blood product availability
  • Better management of hypertensive disorders
  • Advanced neonatal resuscitation

Maternal and Perinatal Outcomes [4,11]

• Maternal mortality: 1-2% in severe cases (primarily from hemorrhagic shock, DIC)
• Perinatal mortality:
  • "Mild abruption: 3-5%"
  • "Moderate abruption: 10-20%"
  • "Severe abruption: 30-60%"
  • "Overall: 15-25% (represents 10-20% of all perinatal deaths)"
• Neonatal complications (survivors):
  • "Preterm birth: 40-50%"
  • "Low birth weight: 35-45%"
  • "Respiratory distress syndrome: 20-30%"
  • "Intraventricular hemorrhage: 5-10%"
  • "Cerebral palsy: 2-4% (increased risk with severe abruption)"

Classification Systems

By Clinical Severity (Modified Sher Classification)

By Anatomical Pattern

1. Revealed (External) Hemorrhage (80%)

   • Blood dissects between membranes and myometrium
   • Passes through cervix → visible vaginal bleeding
   • Amount of bleeding better correlates with actual blood loss
   • Generally better prognosis (earlier recognition)

2. Concealed (Internal) Hemorrhage (10-20%)

   • Blood trapped behind placenta and membranes
   • No or minimal vaginal bleeding
   • Significantly underestimates true blood loss
   • Up to 2,000 mL can accumulate without external signs
   • Associated with:
     • Rapid maternal decompensation
     • Higher rate of DIC
     • Worse fetal outcomes
     • Central/fundal placental location

3. Mixed Pattern (20%)

   • Combination of revealed and concealed bleeding
   • Most common presentation
   • Variable correlation between visible blood and actual loss

---

Risk Factors

Maternal Risk Factors

Hypertensive Disorders (Relative Risk 2.5-3.5) [12]

• Chronic hypertension: RR 1.8-2.4
  • Risk increases with duration of hypertension
  • Highest risk with poor blood pressure control
• Preeclampsia: RR 2.1-4.0
  • Early-onset preeclampsia carries higher risk
  • Severe features increase risk substantially
• Eclampsia: RR 5.0-7.5
• HELLP syndrome: RR 3.0-4.5

Mechanism: Abnormal placentation, endothelial dysfunction, vasospasm leading to decidual vessel rupture

Previous Abruption (Highest Risk Factor) [6]

• After one previous abruption: RR 10-15 (absolute risk 5-17%)
• After two previous abruptions: RR 20-25 (absolute risk 20-25%)
• Risk factors for recurrence:
  • Severe index abruption
  • Early gestational age at index event
  • Associated maternal hypertension
  • Continued smoking

Substance Use

• Cocaine use: RR 4.0-10.0 [13]
  • Acute vasoconstriction and hypertension
  • Risk persists for 24-48 hours after use
  • Associated with catastrophic abruption pattern
• Tobacco smoking: RR 1.4-2.5 (dose-dependent)

  • 10 cigarettes/day: RR 2.0

  • 20 cigarettes/day: RR 2.5

  • "Mechanism: Hypoxia, carboxyhemoglobin, decidual necrosis"
• Amphetamine use: RR 3.0-5.0
• Alcohol: Controversial association, likely confounded by other factors

Trauma [14]

• Motor vehicle accidents: Most common traumatic cause
  • Risk correlates with severity of impact
  • Lap belt injuries increase risk
  • Abruption can occur with minor trauma
• Domestic violence: 4-8% of abruptions
• Falls
• Direct abdominal trauma
• Seat belt sign correlates with abruption risk
• Monitoring protocol: Minimum 4-6 hours CTG monitoring after trauma; 24 hours if contractions or bleeding present

Advanced Maternal Age

• Age > 35 years: RR 1.5-2.0
• Age > 40 years: RR 2.0-3.0
• Independent risk factor even after controlling for parity and comorbidities

Multiparity

• Grand multiparity (≥5): RR 1.5-2.5
• Mechanism: Decidual thinning, altered uterine vasculature

Other Maternal Factors

• Thrombophilia: RR 2.0-7.5 (varies by specific disorder)
  • "Factor V Leiden: RR 2.0-3.0"
  • "Prothrombin G20210A: RR 2.5-4.0"
  • "Antiphospholipid syndrome: RR 4.0-7.5"
• Uterine anomalies: RR 2.0-3.0
• Leiomyomas: RR 1.5-2.5 (especially retroplacental)
• Chorioamnionitis: RR 2.5-4.0
• Polyhydramnios: RR 2.0-3.0 (especially with rapid decompression)
• Diabetes mellitus: RR 1.5-2.0 (with vascular complications)
• Renal disease: RR 2.0-3.0
• Systemic lupus erythematosus: RR 3.0-5.0

Pregnancy-Related Risk Factors

Multiple Gestation

• Twins: RR 2.0-3.0
• Higher-order multiples: RR 3.0-4.5
• Risk highest after delivery of first twin (acute uterine decompression)

Placental Factors

• Large placenta (> 25th percentile for gestational age)
• Marginal cord insertion
• Chronic abruption-oligohydramnios sequence (CAOS)

Premature Rupture of Membranes

• Preterm PROM: RR 2.5-4.0
• Mechanism: Sudden uterine decompression, ascending infection

Rapid Uterine Decompression

• Post-amniocentesis (large volume)
• Delivery of first twin
• Spontaneous PPROM with polyhydramnios

Iatrogenic Risk Factors

• External cephalic version: 0.3-1% risk
• Abdominal trauma during invasive procedures
• Cocaine use during labor induction
• Uterine instrumentation

Non-Modifiable Risk Factors

Ethnicity

• African descent: RR 1.5-2.0 vs European
• Asian: RR 0.7-0.9 vs European
• Hispanic: RR 1.0-1.2 vs European
• Mechanism likely multifactorial: genetics, socioeconomic factors, comorbidities

Male Fetal Sex: RR 1.1-1.3 (modest increase)

---

Pathophysiology

Initiating Mechanism

Primary Event: Decidual Hemorrhage

1. Vascular Rupture

   • Rupture of maternal spiral arteries in decidua basalis
   • Triggered by:
     • Abnormal placentation (defective trophoblast invasion)
     • Acute hypertension (vessel rupture)
     • Trauma (shearing forces)
     • Thrombosis with vessel wall necrosis

2. Hematoma Formation

   • Blood accumulates in decidual space
   • Creates expanding retroplacental clot
   • Clot size determines severity:
     • less than 60 mL: Usually mild, may be asymptomatic
     • 60-250 mL: Moderate symptoms, fetal compromise possible

     • 250 mL: Severe symptoms, high risk fetal demise

     • 500 mL: DIC risk increases significantly

3. Progressive Separation

   • Expanding hematoma dissects between placenta and decidua
   • Compression of intervillous space
   • Reduction in functional placental surface area
   • Placental infarction at margins of separation
   • Critical threshold: > 50% separation → fetal death highly likely

Consequences of Placental Separation

Uteroplacental Insufficiency

• Reduced blood flow to intervillous space
• Decreased oxygen delivery to fetus
• Fetal hypoxia and acidosis
• Severity proportional to extent of separation

Uterine Irritability

• Blood is a uterine irritant
• Stimulates myometrial contractions
• High-frequency, low-amplitude contractions
• May progress to tetanic contractions (especially severe abruption)
• Increased baseline uterine tone (hypertonia)

Hemorrhage Patterns

Revealed Hemorrhage

• Blood tracks between membranes and decidua
• Exits via cervix → vaginal bleeding
• Typically dark red (venous origin)
• May contain clots
• Amount visible correlates better with total blood loss

Concealed Hemorrhage

• Blood trapped behind placenta
• Enclosed by intact membranes
• No communication with cervical os
• Accumulation limited by:
  • Myometrial distensibility
  • Membrane integrity
  • Position of placental edge

Couvelaire Uterus (Uteroplacental Apoplexy) [15]

Definition: Extravasation of blood into and through the myometrium, extending to the uterine serosa and occasionally into broad ligament

Pathophysiology

1. Severe retroplacental hemorrhage with high pressure
2. Blood dissects through decidua into myometrium
3. Interstitial hemorrhage between muscle fibers
4. May extend through serosa (ecchymotic, purple-blue appearance)
5. Blood may track into broad ligament, ovaries, peritoneum

Clinical Significance

• Occurs in ~5% of severe abruptions
• Classical "purple/blue bruised" uterine appearance at cesarean
• Does NOT require hysterectomy (historical misconception)
• May impair myometrial contractility → increased postpartum hemorrhage risk
• Associated findings:
  • Uterine atony after delivery
  • Increased risk of blood transfusion
  • Higher rate of DIC

Management Implications

• Anticipate postpartum hemorrhage
• Aggressive uterotonic administration:
  • "Oxytocin infusion (high dose: 40-80 units in 1L over 4-6 hours)"
  • Carboprost 250 mcg IM (repeat q15min, max 8 doses)
  • Misoprostol 800-1000 mcg sublingual or rectal
• Consider prophylactic uterine compression sutures (B-Lynch)
• Interventional radiology backup if available
• Hysterectomy rarely required (only if medical/surgical management fails)

Disseminated Intravascular Coagulation (DIC) [3,16]

Incidence

• 10-20% of severe abruptions
• Up to 38% with associated fetal demise
• Risk increases with:
  • Concealed hemorrhage
  • Delay to delivery > 4-6 hours
  • Fetal demise
  • Massive transfusion

Pathophysiological Cascade

1. Trigger: Tissue Factor Release

   • Damaged placental tissue releases thromboplastin
   • Activates extrinsic coagulation pathway
   • Initiates widespread coagulation cascade

2. Consumption Phase

   • Widespread microvascular thrombosis
   • Consumption of clotting factors:
     • Fibrinogen (first and most severely depleted)
     • Factor V
     • Factor VIII
     • Platelets
   • Deposition of fibrin in microvasculature

3. Fibrinolytic Phase

   • Secondary fibrinolysis activated
   • Generation of fibrin degradation products (FDPs)
   • D-dimer elevation
   • Further consumption of clotting factors

4. End-Organ Dysfunction

   • Microvascular thrombosis causes ischemia:
     • Renal: Acute tubular necrosis, cortical necrosis
     • Hepatic: Hepatocellular injury
     • Pulmonary: ARDS
     • Cerebral: Stroke, encephalopathy
   • Bleeding from multiple sites (venipuncture, surgical incisions, mucosal surfaces)

Laboratory Findings in DIC

Clinical Manifestations

• Oozing from IV sites, surgical incisions
• Mucosal bleeding (gingival, nasal)
• Hematuria
• Petechiae, purpura, ecchymoses
• Massive obstetric hemorrhage unresponsive to uterotonic agents

---

Clinical Presentation

Cardinal Presenting Features

Classic Triad (Present in only 30-50% of cases) [1]

1. Vaginal bleeding (70-80%)
2. Uterine tenderness/pain (66%)
3. Fetal distress or demise (60%)

Absence of triad does NOT exclude diagnosis - high index of suspicion essential

Symptom Profile

Physical Examination Findings

General Appearance

• Distressed, anxious
• Diaphoresis (if hemodynamically compromised)
• Pallor (anemia, shock)

Vital Signs

• Tachycardia: Often first sign of significant hemorrhage
  • "Mild: HR 90-100 bpm"
  • "Moderate: HR 100-120 bpm"
  • "Severe: HR > 120 bpm"
• Hypotension: Late finding (> 20-30% blood volume loss)
  • "SBP less than 100 mmHg: Concerning in pregnancy"
  • "SBP less than 90 mmHg: Shock, requires immediate resuscitation"
• Tachypnea: Compensatory respiratory alkalosis
• Hypertension: May be present if preeclampsia/chronic HTN underlying cause

Abdominal Examination

• Uterine tone: Increased baseline tone (hypertonia)
  • "Mild: Firm but indent-able"
  • "Moderate: Tense, difficult to palpate fetal parts"
  • Severe: "Woody hard," tetanic, board-like rigidity
• Uterine tenderness: Localized (over abruption site) or diffuse
• Fundal height: May be increased (concealed hemorrhage accumulation)
  • Serial measurements showing rapid increase highly suspicious
• Fetal parts: Difficult or impossible to palpate (severe cases)
• Contractions: High frequency, may be palpably constant

Pelvic/Vaginal Examination

• IMPORTANT: Perform gentle speculum exam BEFORE digital exam to exclude placenta previa
• Visualize blood:
  • "Color: Dark red (venous), occasionally bright red"
  • "Consistency: May contain clots"
  • "Amount: Document but remember concealed component"
• Cervical dilation: Often advanced (contractions from uterine irritability)
• Cervical effacement: Frequently progressed
• Membrane status: Intact or ruptured
• Presenting part: Station and position

Clinical Presentations by Severity

Mild Abruption (Grade 1)

• Minimal symptoms
• Slight vaginal bleeding (less than 500 mL total)
• Uterus soft or mildly tender
• Normal maternal vital signs
• Fetal heart rate reassuring
• Coagulation studies normal
• May be diagnosed only after delivery (small retroplacental clot)

Moderate Abruption (Grade 2)

• Moderate abdominal pain
• Vaginal bleeding 500-1,500 mL (may be underestimated if concealed)
• Uterine tenderness and irritability
• Maternal tachycardia (HR 100-120)
• Fetal heart rate shows:
  • Tachycardia (> 160 bpm)
  • Reduced variability
  • Variable or late decelerations
• Fibrinogen 150-250 mg/dL
• May have early DIC laboratory changes

Severe Abruption (Grade 3)

• Severe, constant abdominal pain
• Heavy vaginal bleeding (> 1,500 mL) or concealed hemorrhage
• Uterus tetanically contracted ("woody hard")
• Maternal shock (hypotension, tachycardia > 120)
• Fetal distress or demise common
• DIC established:
  • Fibrinogen less than 150 mg/dL
  • Platelets less than 100,000/μL
  • Elevated PT/PTT
  • Clinical bleeding (oozing from IV sites)

Chronic Abruption-Oligohydramnios Sequence (CAOS)

• Subacute presentation over days to weeks
• Recurrent small bleeds
• Progressive oligohydramnios
• Intrauterine growth restriction (IUGR)
• Jelly-like, gelatinous placenta at delivery
• Associated with:
  • Preterm birth
  • Pulmonary hypoplasia (if severe oligohydramnios)
  • Orthopedic deformities (positional)

Fetal Assessment

Continuous Cardiotocography (CTG) Findings

Umbilical Artery Doppler (if available)

• Increased resistance (elevated S/D ratio, reduced or absent end-diastolic flow)
• Reversed end-diastolic flow: Severe compromise
• Utility limited in acute setting (more useful for chronic placental insufficiency)

---

Red Flags and Life-Threatening Features

Maternal Critical Warnings

Fetal Critical Warnings

High-Risk Scenarios Predicting Poor Outcome

Maternal

• Concealed retroplacental clot > 500 mL
• Fibrinogen less than 100 mg/dL
• Platelets less than 50,000/μL
• Class III-IV hemorrhagic shock (> 30-40% blood loss)
• Couvelaire uterus identified at cesarean
• Associated severe preeclampsia with end-organ dysfunction
• Delay from symptom onset to delivery > 6 hours

Fetal

• Persistent bradycardia or absent FHR
• Estimated placental separation > 50%
• Gestational age less than 28 weeks (viability concerns)
• Evidence of severe fetomaternal hemorrhage (Kleihauer-Betke > 30 mL)

---

Differential Diagnosis

Primary Differentials for Third-Trimester Bleeding

Comparison: Placental Abruption vs Placenta Previa

Must-Not-Miss Diagnoses

1. Uterine rupture: Catastrophic; requires immediate laparotomy
2. Vasa previa with rupture: Fetal exsanguination rapid; emergency cesarean
3. Abdominal aortic aneurysm rupture: Rare in pregnancy; maternal death imminent
4. Ectopic pregnancy (if less than 20 weeks): Hemodynamic collapse possible

---

Diagnostic Approach

Initial Assessment and Stabilization

Systematic ABCDE Approach

A - Airway

• Assess patency
• Prepare for intubation if altered mental status or impending respiratory failure

B - Breathing

• Oxygen saturation > 95%
• Supplemental O₂ if needed (non-rebreather mask 15 L/min)
• Respiratory rate, work of breathing

C - Circulation

• IV access: Two large-bore (16-18G) peripheral IVs
  • Consider central venous access if shock or difficult peripheral access
• Blood draws: Send all labs with initial IV placement
  • CBC with differential
  • Type and crossmatch (6-8 units pRBCs)
  • "Coagulation panel: PT, PTT, INR, fibrinogen"
  • D-dimer, fibrin degradation products
  • Comprehensive metabolic panel (renal function)
  • Kleihauer-Betke test (Rh-negative mothers)
• Vital signs: Every 5-15 minutes in acute phase
• Fluid resuscitation: Begin immediately
  • "Initial: 2L crystalloid (LR or NS) wide open"
  • Transition to blood products early if ongoing hemorrhage

D - Disability

• Neurological status (alert, responds to voice/pain, unresponsive)
• Rule out eclampsia if altered mental status with hypertension

E - Exposure

• Inspect for vaginal bleeding
• Assess fundal height
• Abdominal exam for uterine tone and tenderness

F - Fetal Assessment

• Immediate: Confirm fetal heart tones (Doppler or ultrasound)
• Continuous CTG monitoring: Mandatory for all suspected abruptions

Laboratory Evaluation

Essential Initial Tests

Serial Monitoring

• Repeat coagulation panel every 1-2 hours during active resuscitation
• Hemoglobin every 2-4 hours or after each transfusion
• Point-of-care testing (if available):
  • "Thromboelastography (TEG) or Rotational Thromboelastometry (ROTEM): Real-time coagulation assessment"
  • "Bedside clot test: 5 mL blood in red-top tube; should clot in 6-8 minutes (failure suggests low fibrinogen)"

Fetal Monitoring

Continuous Cardiotocography (CTG/EFM) [17]

• Mandatory for all suspected abruptions
• Duration:
  • Minimum 4 hours if trauma without bleeding/contractions
  • Minimum 24 hours if bleeding or contractions present
  • Continuous until delivery if diagnosis confirmed
• Interpretation:
  • Baseline rate, variability, accelerations, decelerations
  • Concerning patterns warrant expedited delivery
• Limitations:
  • Cannot quantify extent of abruption
  • Reassuring tracing does NOT exclude small abruption

Biophysical Profile (if chronic/mild abruption)

• Fetal breathing, movement, tone, amniotic fluid volume
• Non-stress test component
• Score less than 6/10 concerning

Umbilical Artery Doppler

• Limited utility in acute abruption
• May show increased resistance in chronic cases
• Absent or reversed end-diastolic flow: Severe compromise

Imaging Studies

Bedside Ultrasound [8]

Indications

• Confirm fetal viability
• Exclude placenta previa before digital exam
• Identify retroplacental clot (if visible)
• Assess amniotic fluid volume

Findings Suggestive of Abruption

• Retroplacental clot:
  • "Acute (less than 1 week): Hyperechoic or isoechoic (difficult to visualize)"
  • "Subacute (1-2 weeks): Hypoechoic"
  • "Chronic (> 2 weeks): Complex, mixed echogenicity"
• Thickened, elevated placental edge
• Subchorionic hematoma
• Oligohydramnios (chronic abruption)
• Intrauterine fetal demise

Limitations (CRITICAL)

• Sensitivity: Only 25-60% for acute abruption
• Normal ultrasound does NOT exclude abruption
• Acute blood is isoechoic to placenta → difficult to distinguish
• Small abruptions frequently missed
• Operator-dependent
• Do NOT delay treatment waiting for ultrasound

MRI

• Rarely used (time-consuming, not practical in emergency)
• May identify chronic hematomas or evaluate placental abnormalities
• No advantage over ultrasound in acute setting

Clinical Diagnosis

Key Principle: Placental Abruption is a CLINICAL Diagnosis [7]

Diagnostic Criteria (Meet ≥2 of the following):

1. Vaginal bleeding in second half of pregnancy
2. Uterine tenderness or hypertonicity
3. Non-reassuring fetal status or fetal demise
4. Evidence of coagulopathy or DIC

High Suspicion Scenarios

• Classic triad present
• Concealed hemorrhage pattern (increasing fundal height, shock without visible bleeding)
• Risk factors present (hypertension, trauma, cocaine, previous abruption)
• Bloody amniotic fluid at cesarean section

Definitive Diagnosis: Retroplacental clot identified at delivery (pathology confirms)

---

Management

Initial Resuscitation and Stabilization

Maternal Resuscitation Priority

Step 1: Establish Vascular Access and Send Labs

• Two large-bore peripheral IVs (16-18G minimum)
  - Right and left antecubital fossa preferred
  - "If difficult access: Consider ultrasound-guided, EJ, or central line"
• Simultaneously draw all labs (see Laboratory Evaluation section)
• If shock present: Consider arterial line for continuous BP monitoring

Step 2: Volume Resuscitation [18]

Initial Fluid Therapy:
• 2L Lactated Ringer's or Normal Saline wide open (bolus)
• Reassess after each liter

Hemodynamic Goals:
• SBP > 100 mmHg
• MAP > 65 mmHg
• HR less than 100 bpm
• Urine output > 0.5-1 mL/kg/hr
• Normal mental status

Transition to Blood Products:
If after 2L crystalloid:
  - Persistent hypotension (SBP less than 90-100)
  - Ongoing hemorrhage
  - Hb less than 7-8 g/dL
  - Evidence of coagulopathy
→ ACTIVATE MASSIVE TRANSFUSION PROTOCOL

Step 3: Massive Transfusion Protocol [9,18]

Indications for Activation

• Hemorrhagic shock unresponsive to 2L crystalloid
• Ongoing brisk bleeding
• Suspicion of > 2,000 mL blood loss
• Fibrinogen less than 200 mg/dL with active bleeding
• Clinical DIC

1:1:1 Ratio Transfusion Strategy

• pRBCs: FFP: Platelets = 1:1:1
• Example: 6 units pRBCs : 6 units FFP : 1 apheresis platelet unit

Blood Product Goals

Fibrinogen Replacement Strategy (Critical in Abruption) [19]

• Fibrinogen is first and most severely depleted clotting factor
• Target > 200 mg/dL (some experts recommend > 300 mg/dL if ongoing bleeding)
• Cryoprecipitate preferred:
  • Each 10-unit pool increases fibrinogen ~70-100 mg/dL
  • Contains concentrated fibrinogen, Factor VIII, vWF, Factor XIII
• Alternative: Fibrinogen concentrate (if available, 2-4g dose)

Tranexamic Acid (TXA) [9]

• Antifibrinolytic agent
• Evidence: Reduces hemorrhage-related mortality in trauma and PPH
• Dosing: 1g IV over 10 minutes, followed by 1g IV over 8 hours
• Timing critical: Benefit diminishes after 3 hours from bleeding onset
• Contraindications: Known thrombophilia (relative)
• Side effects: Nausea, vomiting; thrombosis risk (theoretical in pregnancy)

Monitoring During Resuscitation

• Vital signs every 5-15 minutes
• Continuous pulse oximetry
• Continuous CTG (fetal monitoring)
• Urine output (Foley catheter)
• Repeat labs:
  • CBC every 2-4 hours or post-transfusion
  • Coagulation panel (fibrinogen, PT/PTT, platelets) every 1-2 hours
  • Arterial or venous blood gas (lactate, pH)

Delivery Decision-Making

Critical Decision: Timing and Mode of Delivery

Indications for IMMEDIATE Emergency Cesarean Section [5,20]

Indications for URGENT Delivery (Balance Stabilization + Delivery)

Vaginal Delivery Considerations

Appropriate if ALL criteria met:

1. Maternal hemodynamically stable
2. Fetal status reassuring OR fetal demise with stable mother
3. Cervix favorable (≥3 cm dilated, ≥50% effaced) OR labor progressing rapidly
4. Continuous monitoring available
5. Immediate cesarean capability if deterioration
6. No other obstetric contraindications to vaginal delivery

Advantages:

• Avoid surgical morbidity if fetal demise
• Faster than cesarean if cervix very favorable
• Lower blood loss if mother stable

Risks:

• Progression of abruption during labor
• Fetal deterioration requiring emergency cesarean
• Prolonged labor poorly tolerated

Management During Labor:

• Continuous CTG monitoring
• Avoid prolonged labor (augment if needed)
• Serial fibrinogen monitoring
• Amniotomy after stabilization (may speed labor)
• Anticipate postpartum hemorrhage

Cesarean Section Indications

Absolute:

• Maternal hemodynamic instability
• Non-reassuring fetal status with viable fetus
• Standard obstetric indications (e.g., prior classical cesarean, complete previa)

Relative:

• Severe abruption even if currently stable (high risk deterioration)
• Unfavorable cervix with need for delivery
• Failed induction
• Maternal preference in context of severe abruption

Intraoperative Management

Preoperative Preparation

• Notify anesthesia (high-risk, possible GA if hemodynamically unstable)
• Blood products in OR (at least 4 units pRBCs, 4 FFP immediately available)
• Neonatal resuscitation team present
• Interventional radiology on standby (if available, for refractory PPH)
• Consent includes: Transfusion, hysterectomy, ICU admission

Anesthetic Considerations

• Neuraxial (spinal/epidural): Preferred if hemodynamically stable and no coagulopathy
  • Check platelets > 70-80,000/μL and fibrinogen > 200 mg/dL
• General anesthesia: If unstable, coagulopathy, or emergency
• Avoid aortocaval compression: Left lateral tilt until delivery

Surgical Technique

• Standard low transverse cesarean unless specific indication for classical
• Anticipate findings:
  • Retroplacental clot (confirm diagnosis)
  • Couvelaire uterus (ecchymotic, purple-blue myometrium)
  • Difficult hemostasis due to DIC/atony
• Uterotonic agents:
  • "Oxytocin: 10 units IM + 20-40 units in 1L continuous infusion (high dose may be needed)"
  • "Consider prophylactic additional agents:"
    • Carboprost 250 mcg IM (avoid if asthma)
    • Misoprostol 800-1000 mcg sublingual or rectal
• Hemostasis maneuvers (if atony despite uterotonics):
  • Bimanual uterine massage
  • Uterine compression sutures (B-Lynch, Cho, Hayman)
  • Bilateral uterine artery ligation
  • Bilateral O'Leary sutures (utero-ovarian ligament ligation)
  • Bakri balloon tamponade
• Hysterectomy: Last resort if above measures fail
  • Required in less than 1-3% of severe abruptions
  • Higher risk with Couvelaire uterus, DIC, placenta accreta

Postoperative Care

• High-dependency or ICU monitoring (if severe)
• Transfusion continued as needed
• Serial labs: CBC, coagulation panel
• Monitor for complications:
  • Postpartum hemorrhage
  • Acute kidney injury
  • DIC progression
  • Sepsis

Management of Specific Complications

Disseminated Intravascular Coagulation (DIC) [3,16]

Treatment Principles:

1. Remove trigger: Deliver fetus and placenta urgently
2. Replace consumed factors: Aggressive blood product support
3. Avoid delay: DIC worsens with time; delivery resolves trigger

Replacement Protocol:

Fibrinogen less than 200 mg/dL:
  → Cryoprecipitate 10 units (recheck in 1-2 hours)
  → Target > 200 mg/dL (> 300 mg/dL if ongoing bleeding)

Platelets less than 50,000/μL:
  → 1 apheresis unit or 6-pack pooled platelets
  → Target > 50,000/μL (> 75,000 for surgery)

PT/INR > 1.5:
  → FFP 15-20 mL/kg (4-6 units)
  → Target INR less than 1.5

Ongoing consumption:
  → Continue 1:1:1 ratio transfusion
  → Recheck labs every 1-2 hours
  → Consider TXA if not already given

Resolution: Typically improves rapidly (hours) after delivery and placental removal

Couvelaire Uterus [15]

Recognition: Purple-blue ecchymotic appearance of uterus at cesarean section

Management:

• Does NOT mandate hysterectomy (historical teaching now refuted)
• Expect uterine atony:
  • Aggressive uterotonic therapy (see Intraoperative Management)
  • Early consideration of compression sutures
  • Bakri balloon if medical management inadequate
• Hysterectomy only if refractory postpartum hemorrhage

Acute Kidney Injury [21]

• Occurs in 5-10% of severe abruptions
• Mechanisms: Hypovolemic shock, DIC (microvascular thrombosis), cortical necrosis (rare)
• Prevention: Early aggressive resuscitation, maintain urine output > 0.5 mL/kg/hr
• Management:
  • Fluid balance monitoring
  • Avoid nephrotoxins
  • Renal consultation if Cr rising or oliguria persists
  • Dialysis if severe (rarely required)

Special Scenarios

Preterm Abruption (less than 37 weeks) [22]

Mild Abruption, Stable Mother and Fetus (less than 34 weeks)

Expectant Management May Be Appropriate If:

• Minimal bleeding, resolved
• Reassuring continuous CTG
• No maternal hemodynamic compromise
• No evidence of coagulopathy
• Capability for immediate delivery if needed

Interventions:

• Corticosteroids for fetal lung maturity:
  • Betamethasone 12 mg IM x2 doses (24 hours apart), OR
  • Dexamethasone 6 mg IM q12h x4 doses
  • "Benefit: 24 weeks to 34+6 weeks"
• Magnesium sulfate for neuroprotection (less than 32 weeks):
  • 4-6g IV loading dose, then 1-2 g/hr infusion
  • Continue until delivery or 24 hours
• Tocolysis: Generally CONTRAINDICATED
  • May mask uterine irritability indicating worsening abruption
  • Consider only if preterm labor without abruption confirmed
• Hospital admission: Continuous monitoring minimum 24-48 hours
• Serial ultrasounds: Growth, amniotic fluid volume
• Antepartum testing: NST twice weekly, BPP weekly

Risks of Expectant Management:

• Progression of abruption (15-20%)
• Fetal demise
• Preterm labor
• Must have very close monitoring and immediate delivery capability

Moderate-Severe Abruption (less than 34 weeks):

• Deliver despite prematurity
• Risks of continuing pregnancy exceed prematurity risks
• Give corticosteroids and magnesium if time permits (do NOT delay delivery)

Placental Abruption with Fetal Demise

Management Focus: Maternal stabilization and safety

Mode of Delivery:

• Vaginal delivery preferred if mother hemodynamically stable
  • Avoids surgical morbidity
  • DIC risk high; neuraxial anesthesia contraindicated if coagulopathic
  • Shorter maternal recovery
• Cesarean section if:
  • Maternal hemodynamic instability
  • Uncontrollable hemorrhage
  • Standard obstetric contraindications to vaginal delivery
  • Unfavorable cervix with worsening maternal status

Labor Management:

• Continuous maternal monitoring
• Aggressive correction of coagulopathy
• Serial labs (fibrinogen critical)
• Amniotomy to speed labor
• Oxytocin augmentation
• Pain management (epidural contraindicated if DIC; use IV opioids)

Psychosocial Support:

• Involve bereavement counseling
• Offer chaplain services
• Pathology examination of fetus and placenta
• Discuss autopsy (may provide answers)
• Follow-up appointment for recurrence risk counseling

Abruption Associated with Hypertensive Disorders [12]

Preeclampsia/Eclampsia + Abruption

Additional Considerations:

• Magnesium sulfate for seizure prophylaxis:
  • 4-6g IV load, then 1-2 g/hr maintenance
  • Continue 24 hours postpartum
  • Monitor for toxicity (reflexes, respiratory rate, urine output)
• Control severe hypertension (SBP ≥160 or DBP ≥110):
  • Labetalol 20 mg IV push, then 40-80 mg q10min (max 300 mg), OR
  • Hydralazine 5-10 mg IV q20min, OR
  • Nifedipine immediate-release 10-20 mg PO q20-30min
• HELLP syndrome overlap:
  • Check LDH, AST, platelet count
  • May compound coagulopathy
  • Delivery is definitive treatment

Trauma-Related Abruption [14]

Mechanisms:

• Shearing forces from deceleration (MVA)
• Direct abdominal impact
• Uterine compression against spine

Initial Management:

• Trauma team activation (Advanced Trauma Life Support protocol)
• Maternal stabilization priority
• Secondary survey includes obstetric assessment
• Kleihauer-Betke test
• Continuous fetal monitoring minimum 4-6 hours (24 hours if contractions/bleeding)
• RhoGAM if Rh-negative

Delivery Decisions:

• Most trauma-related abruptions are mild
• Deliver if maternal instability or non-reassuring fetal status
• Otherwise, may observe with monitoring

Perimortem Cesarean Section:

• If maternal cardiac arrest > 20 weeks gestation
• Begin within 4 minutes, deliver by 5 minutes of arrest
• May improve maternal resuscitation outcomes

---

Disposition and Follow-Up

Admission Criteria

All suspected or confirmed placental abruptions require admission [7]

Labor and Delivery / Maternity Unit:

• Continuous fetal and maternal monitoring
• Immediate operating room availability
• Capability for emergency cesarean section

Intensive Care Unit / High-Dependency Unit: Indications:

• Hemorrhagic shock requiring ongoing resuscitation
• Massive transfusion protocol activated
• DIC with multiorgan dysfunction
• Acute kidney injury requiring intensive management
• Mechanical ventilation required
• Severe hypertensive emergency (eclampsia, hypertensive encephalopathy)
• Postoperative instability

Postpartum Monitoring

Maternal Monitoring (First 24-48 Hours)

Neonatal Care

• NICU involvement if:
  • Gestational age less than 34-35 weeks
  • Respiratory distress
  • Evidence of hypoxic-ischemic injury
  • Anemia (Hb less than 12-13 g/dL at birth)
  • Kleihauer-Betke showing significant fetomaternal hemorrhage
• Assess for:
  • Anemia requiring transfusion
  • Hyperbilirubinemia
  • Neurodevelopmental injury (HIE)

Complications to Monitor

Early (0-48 hours):

• Postpartum hemorrhage (uterine atony, DIC)
• Acute kidney injury
• Pulmonary edema (from massive fluid resuscitation)
• Anemia requiring transfusion
• Infection (chorioamnionitis, endometritis)
• Thromboembolic events (DVT, PE) - especially after massive transfusion

Late (> 48 hours):

• Anemia
• Endometritis
• Wound infection (if cesarean)
• Psychological trauma (grief, PTSD, especially if fetal demise)

Postpartum Counseling

Recurrence Risk [6]

• After one abruption: 5-17% (average 10%)
• After two abruptions: 20-25%
• Factors increasing recurrence:
  • Severe index abruption
  • Early gestational age at index event (less than 34 weeks)
  • Chronic hypertension
  • Continued smoking or substance use
  • Underlying thrombophilia

Risk Reduction Strategies for Future Pregnancies

• Smoking cessation: Most modifiable risk factor
• Avoid cocaine and amphetamines: Absolute contraindication
• Control chronic hypertension: Target BP less than 140/90 mmHg
• Low-dose aspirin: 81-150 mg daily starting 12-16 weeks (if history of preeclampsia or high-risk factors)
• Early prenatal care: First trimester visit
• Thrombophilia screening: Consider if recurrent abruption, family history, or other thrombotic events
  • "If positive: Prophylactic anticoagulation (LMWH) during pregnancy"
• Serial ultrasounds: Growth scans, amniotic fluid assessment

Subsequent Pregnancy Management [23]

• Preconception counseling: Discuss recurrence risk, risk reduction
• Early dating ultrasound: Confirm viability, dates
• Increased surveillance:
  • Monthly visits first/second trimester
  • Every 2 weeks third trimester
  • Serial growth ultrasounds (every 3-4 weeks from 24-28 weeks)
  • Antenatal testing starting 32-34 weeks (NST, BPP)
• Delivery planning:
  • Target 37-38 weeks gestation (balance preterm vs abruption risk)
  • Consider planned induction at 37-39 weeks
  • Patient education on warning signs

Discharge Criteria

Mother:

• Hemodynamically stable for 24 hours
• No active bleeding (lochia normal amount)
• Adequate urine output, stable renal function
• Hemoglobin stable (> 7-8 g/dL)
• Coagulation parameters normalized or improving
• Able to ambulate, void, tolerate diet
• Pain controlled on oral medications
• Follow-up arranged

Newborn:

• Stable in nursery or NICU plan established
• Feeding adequately
• No evidence of ongoing hemolysis or severe anemia

Discharge Education:

• Warning signs: Heavy bleeding, fever, wound infection, severe pain, leg swelling
• Postpartum depression screening and resources
• Contraception counseling
• Recurrence risk discussed
• Follow-up appointments scheduled

---

Key Clinical Pearls

Diagnostic Pearls

1. Placental abruption is a clinical diagnosis - do NOT delay management waiting for ultrasound confirmation; sensitivity is only 25-60% [7,8]

2. Concealed abruption is the most dangerous presentation - minimal vaginal bleeding with significant maternal shock suggests massive retroplacental hemorrhage; increasing fundal height on serial exams is ominous [2]

3. Maternal tachycardia is often the first sign of significant hemorrhage before hypotension develops; shock index (HR/SBP) > 1.0 indicates severe blood loss

4. Normal ultrasound does NOT exclude abruption - acute blood is isoechoic to placenta; small and moderate abruptions are frequently missed on imaging [8]

5. Fibrinogen is the best early marker of coagulopathy - falls before PT/PTT prolongation; level less than 200 mg/dL is concerning and less than 150 mg/dL indicates high DIC risk [3,19]

6. Dark vaginal bleeding with a "woody hard" uterus - classic presentation of severe abruption; uterus tetanically contracted

7. Kleihauer-Betke test serves dual purpose - quantifies fetomaternal hemorrhage for RhoGAM dosing AND correlates with abruption severity; large fetal-maternal bleed suggests worse prognosis

Management Pearls

1. "Treat the mother first, save the baby second" - maternal resuscitation is priority; aggressive volume replacement and blood products improve both maternal and fetal outcomes [18]

2. Fibrinogen replacement is critical - most depleted clotting factor in abruption-related DIC; early aggressive replacement with cryoprecipitate (target > 200 mg/dL, preferably > 300 mg/dL if ongoing bleeding) [19]

3. Tranexamic acid within 3 hours - proven benefit in obstetric hemorrhage; give early (1g IV) if bleeding within 3-hour window [9]

4. 1:1:1 massive transfusion ratio - pRBCs:FFP:Platelets = 1:1:1 improves outcomes in severe hemorrhage; avoid crystalloid-only resuscitation in ongoing bleeding [18]

5. Delivery is the definitive treatment - DIC and hemorrhage will not resolve until placenta is delivered; do NOT delay for complete coagulopathy correction (correct simultaneously during cesarean) [20]

6. Vaginal delivery is acceptable if fetal demise - avoid cesarean morbidity in stable mother; amniotomy and oxytocin augmentation speed labor; still requires aggressive coagulopathy management

7. Couvelaire uterus does NOT require hysterectomy - historical myth; aggressive uterotonic therapy and compression sutures usually successful; hysterectomy only if refractory PPH [15]

8. Avoid tocolysis - may mask uterine irritability signaling worsening abruption; contraindicatedin abruption

Prognostic Pearls

1. Extent of separation determines fetal outcome - less than 25% separation usually well-tolerated; 25-50% high risk fetal distress; > 50% nearly always results in fetal demise [4]

2. Concealed abruption has higher mortality - both maternal and fetal; delayed recognition and underestimation of blood loss contribute [2]

3. DIC increases maternal and fetal mortality substantially - associated with severe abruption; fibrinogen less than 100 mg/dL is particularly ominous [3]

4. Recurrence risk is highest in early, severe abruptions - especially if less than 34 weeks and Grade 3; counseling essential for future pregnancy planning [6]

Communication and Viva Pearls

Opening Statement for Viva: "Placental abruption is the premature separation of a normally implanted placenta from the uterine wall before delivery, occurring in 0.5-1% of pregnancies. It is a leading cause of third-trimester bleeding and perinatal mortality, with maternal mortality of 1-2% and fetal mortality of 20-40% in significant cases. The diagnosis is primarily clinical, based on vaginal bleeding, uterine tenderness, and fetal distress. Management priorities are maternal resuscitation with early blood product support, correction of coagulopathy, and timely delivery."

Structured Approach to Management Question: "My approach would be systematic:

1. Initial assessment: ABCs, establish two large-bore IVs, send labs including CBC, coagulation panel with fibrinogen, type and crossmatch for 6 units
2. Resuscitation: 2L crystalloid initially, transition to blood products early if ongoing hemorrhage; activate massive transfusion protocol if hemodynamically unstable
3. Fetal assessment: Continuous CTG monitoring; assess viability and wellbeing
4. Definitive management: Decision regarding timing and mode of delivery based on maternal stability and fetal status; emergency cesarean if maternal instability or non-reassuring fetal status; vaginal delivery may be appropriate if stable mother with fetal demise or favorable cervix
5. Complication management: Aggressive correction of coagulopathy with cryoprecipitate (fibrinogen), FFP, platelets; tranexamic acid if within 3 hours; anticipate postpartum hemorrhage"

Common Examiner Questions and Model Answers:

Q: "What is the most important lab value to monitor in placental abruption?" A: "Fibrinogen level is the most important. It is the first and most severely depleted clotting factor in abruption-related DIC. A level below 200 mg/dL is concerning, and below 150 mg/dL indicates significant risk of DIC and massive hemorrhage. I would replace aggressively with cryoprecipitate targeting fibrinogen above 200 mg/dL, and above 300 mg/dL if ongoing bleeding."

Q: "When would you perform cesarean section versus allow vaginal delivery?" A: "Emergency cesarean section is indicated for maternal hemodynamic instability or non-reassuring fetal status with a viable fetus. Vaginal delivery is appropriate if the mother is stable AND either there is fetal demise or the fetus is stable with a favorable cervix. Even with vaginal delivery, I would ensure capability for immediate cesarean if deterioration occurs, and I would actively manage labor with amniotomy and oxytocin to avoid prolonged labor."

Q: "What is a Couvelaire uterus and does it require hysterectomy?" A: "A Couvelaire uterus, or uteroplacental apoplexy, occurs when blood from a severe retroplacental hematoma dissects into and through the myometrium, giving the uterus a purple-blue ecchymotic appearance. Historically it was thought to mandate hysterectomy, but this is no longer considered necessary. The main concern is increased risk of uterine atony and postpartum hemorrhage. I would manage with aggressive uterotonics, early consideration of compression sutures like B-Lynch if needed, and reserve hysterectomy only for refractory hemorrhage unresponsive to all other measures."

---

References

1. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108(4):1005-1016. doi:10.1097/01.AOG.0000239439.04364.9a

2. Ananth CV, Lavery JA, Vintzileos AM, et al. Severe placental abruption: clinical definition and associations with maternal complications. Am J Obstet Gynecol. 2016;214(2):272.e1-272.e9. doi:10.1016/j.ajog.2015.09.069

3. Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452-463. doi:10.1016/j.ajog.2015.03.034

4. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90(2):140-149. doi:10.1111/j.1600-0412.2010.01030.x

5. American College of Obstetricians and Gynecologists. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186. doi:10.1097/AOG.0000000000002351

6. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85(6):700-705. doi:10.1080/00016340500449915

7. Downes KL, Grantz KL, Shenassa ED. Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review. Am J Perinatol. 2017;34(10):935-957. doi:10.1055/s-0037-1599149

8. Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002;21(8):837-840. doi:10.7863/jum.2002.21.8.837

9. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105-2116. doi:10.1016/S0140-6736(17)30638-4

10. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001;153(4):332-337. doi:10.1093/aje/153.4.332

11. Salihu HM, Bekan B, Aliyu MH, Rouse DJ, Kirby RS, Alexander GR. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol. 2005;193(1):198-203. doi:10.1016/j.ajog.2004.11.023

12. Pariente G, Wiznitzer A, Sergienko R, Mazor M, Holcberg G, Sheiner E. Placental abruption: critical analysis of risk factors and perinatal outcomes. J Matern Fetal Neonatal Med. 2011;24(5):698-702. doi:10.3109/14767058.2010.511346

13. Addis A, Moretti ME, Ahmed Syed F, Einarson TR, Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001;15(4):341-369. doi:10.1016/s0890-6238(01)00154-9

14. Mendez-Figueroa H, Dahlke JD, Vrees RA, Rouse DJ. Trauma in pregnancy: an updated systematic review. Am J Obstet Gynecol. 2013;209(1):1-10. doi:10.1016/j.ajog.2013.01.021

15. Arulkumaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placental abruption: a case report of uteroplacental apoplexy (Couvelaire uterus). Aust N Z J Obstet Gynaecol. 1986;26(2):150-152. doi:10.1111/j.1479-828x.1986.tb01546.x

16. Rattray DD, O'Connell CM, Baskett TF. Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can. 2012;34(4):341-347. doi:10.1016/S1701-2163(16)35214-8

17. Alfirevic Z, Devane D, Gyte GM, Cuthbert A. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2017;2(2):CD006066. doi:10.1002/14651858.CD006066.pub3

18. Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. doi:10.1186/s13054-019-2347-3

19. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266-273. doi:10.1111/j.1538-7836.2007.02297.x

20. Royal College of Obstetricians and Gynaecologists. Antepartum Haemorrhage (Green-top Guideline No. 63). 2011. Updated 2024.

21. Kilpatrick SJ, Matthay MA. Obstetric patients requiring critical care. A five-year review. Chest. 1992;101(5):1407-1412. doi:10.1378/chest.101.5.1407

22. Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol. 1996;88(2):309-318. doi:10.1016/0029-7844(96)00088-9

23. Tikkanen M, Luukkaala T, Gissler M, et al. Decreasing perinatal mortality in placental abruption. Acta Obstet Gynecol Scand. 2013;92(3):298-305. doi:10.1111/aogs.12030

---

Version History

|---------|------|---------|-------|-----------|---------------| | 1.0 | 2025-01-15 | Initial comprehensive version | 588 | 5 | 42/56 (Acceptable) | | 2.0 | 2025-01-10 | Enhanced to Gold Standard: expanded pathophysiology (Couvelaire uterus, DIC cascade), comprehensive risk factors (hypertension, trauma, cocaine), detailed concealed vs revealed bleeding, enhanced fetal monitoring, emergency delivery protocols, massive transfusion guidelines, evidence-based citations | 1,387 | 23 | 54/56 (Gold) |